H.R. 2338 · 114th Congress
To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
- Stage
- In committee
- Sponsor
- Joseph Pitts
- Introduced
- 2015-05-14
- Latest action
- 2015-05-15 · Referred to the Subcommittee on Health.
Subjects
Administrative law and regulatory procedures
Health
Health information and medical records
Medical research
Research administration and funding
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation